Reta - GLP-3

Reta - GLP-3 — frequently asked questions

• What is Reta - GLP-3?

  Reta GLP-3 is a triple agonist targeting GLP-1, GIP, and glucagon receptors, being explored for its powerful metabolic effects, especially in obesity and type 2 diabetes.

• What is the half-life of Reta - GLP-3?

  Reta - GLP-3 has an approximate half-life of Approximately 5–7 days. The half-life determines how often you need to inject to maintain steady blood levels — use the Peptides Calculator half-life calculator to plot your specific dosing schedule and see the decay curve.

• How is Reta - GLP-3 administered?

  Reta - GLP-3 is typically delivered via subcutaneous injection (weekly). The Peptides Calculator app helps you reconstitute the vial with bacteriostatic water, calculate your exact dose in syringe units, and track each injection.

• How does Reta - GLP-3 work?

  Acts on GLP-1, GIP, and glucagon receptors to enhance insulin sensitivity, reduce appetite, and increase energy expenditure.

• What are the researched benefits of Reta - GLP-3?

  Studied benefits of Reta - GLP-3 include: Substantial weight loss, Improved glycemic control, Enhanced metabolic rate. These are research findings only — Peptides Calculator does not provide medical advice; consult a qualified healthcare professional before starting any peptide protocol.

• What are the side effects of Reta - GLP-3?

  Reported side effects of Reta - GLP-3 include: Nausea, Gastrointestinal discomfort, Possible increased heart rate. Always discuss potential side effects with a licensed healthcare provider before using any research peptide.